Strong organic growth in high-margin "Branded pharmaceuticals" and revenue growth in "Parallel import business" segment more than offset slight decline in revenue from "Other healthcare products" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback